Skip to main content
Premium Trial:

Request an Annual Quote

Plexxikon Taps Certara's Software for Drug Discovery Data Analysis

Premium

This week, Certara said that Plexxikon has selected its D360 software solution to support data access and analysis for its drug discovery projects.

Certara said that scientists at Plexxikon are using the software to integrate project data and mine structure activity relationships using information from chemical registration and biological assay databases such as Accelrys’ Isentris and Assay Explorer.

The tool also lets users create their own queries and supports collaboration by providing an automated search and analysis workflow that can be shared with other researchers and reused. Furthermore, D360 enables biologists to assess the quality of screening data before they make it available to chemists for additional analysis.

The financial details of the agreement were not disclosed.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.